Trial
NCT03287271
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Michael McHale
Collaborators
Verastem, Inc.; Nine Girls Ask
Condition
Ovarian Cancer
Intervention
VS-6063
Why stopped
Due to loss of funding
Provenance
Dataset: 2026-07-31 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-31